Definitions

from The American Heritage® Dictionary of the English Language, 5th Edition.

  • noun A protease-inhibiting drug usually used with other drugs to suppress the replication of HIV.

from Wiktionary, Creative Commons Attribution/Share-Alike License.

  • noun pharmacology An anti-retroviral drug of the protease inhibitor class that is used in to treat HIV infected patients.

from WordNet 3.0 Copyright 2006 by Princeton University. All rights reserved.

  • noun a protease inhibitor (trade name Viracept) used in treating HIV usually in combination with other drugs

Etymologies

from The American Heritage® Dictionary of the English Language, 4th Edition

[nelfi-, of unknown origin + -navir, protease inhibitor suff. (from saquinavir).]

Support

Help support Wordnik (and make this page ad-free) by adopting the word nelfinavir.

Examples

  • Importantly, the team found that EGCG only reacted with proteasome inhibitors that have a boronic acid base (including bortezomib) but did not react with several non-boronic acid-based proteasome inhibitors (such as nelfinavir [Viracept®], a treatment for HIV).

    Scientific Blogging 2009

  • Importantly, the team found that EGCG only reacted with proteasome inhibitors that have a boronic acid base (including bortezomib) but did not react with several non-boronic acid-based proteasome inhibitors (such as nelfinavir [Viracept®], a treatment for HIV).

    innovations-report 2009

  • Researchers at the Tulane University School of Medicine, New Orleans, Louisiana have discovered that the HIV-1 protease inhibitors (PIs), such as nelfinavir included in highly active antiretroviral therapy (HAART) regimen for the treatment of HIV-1 patients, induce deleterious effects on insulin secretion mediated through the oxidative stress pathway.

    PhysOrg.com - latest science and technology news stories 2009

  • Importantly, the team found that EGCG only reacted with proteasome inhibitors that have a boronic acid base (including bortezomib) but did not react with several non-boronic acid-based proteasome inhibitors (such as nelfinavir [Viracept (R)], a treatment for HIV).

    Health News from Medical News Today 2009

  • Researchers at the Tulane University School of Medicine, New Orleans, Louisiana have discovered that the HIV-1 protease inhibitors (PIs), such as nelfinavir included in highly active antiretroviral therapy (HAART) regimen for the treatment of HIV-1 patients, induce deleterious effects on insulin secretion mediated through the oxidative stress pathway.

    Health News from Medical News Today 2009

  • In August 2001, Brazilian Health Minister Jose Serra announced the Brazilian government would issue a compulsory license for the manufacture of the antiretroviral drug nelfinavir, whose brand name was Viracept.

    Robert Naiman: Brazil Should Lead on Access to Essential Medicines Robert Naiman 2010

  • In August 2001, Brazilian Health Minister Jose Serra announced the Brazilian government would issue a compulsory license for the manufacture of the antiretroviral drug nelfinavir, whose brand name was Viracept.

    Robert Naiman: Brazil Should Lead on Access to Essential Medicines Robert Naiman 2010

  • In August 2001, Brazilian Health Minister Jose Serra announced the Brazilian government would issue a compulsory license for the manufacture of the antiretroviral drug nelfinavir, whose brand name was Viracept.

    Robert Naiman: Brazil Should Lead on Access to Essential Medicines Robert Naiman 2010

  • In August 2001, Brazilian Health Minister Jose Serra announced the Brazilian government would issue a compulsory license for the manufacture of the antiretroviral drug nelfinavir, whose brand name was Viracept.

    Robert Naiman: Brazil Should Lead on Access to Essential Medicines Robert Naiman 2010

  • And Agouron Pharmaceuticals will soon seek approval for nelfinavir, the first protease inhibitor formulated for children as well as adults.

    Targeting A Deadly Scrap Of Genetic Code 2008

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.